Corrigendum: NDRG1 Inhibition Sensitizes Osteosarcoma Cells to Combretastatin A-4 Through Targeting Autophagy

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2017.558
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Long Non-Coding RNA CTA Sensitizes Osteosarcoma Cells to Doxorubicin Through Inhibition of Autophagy

Oncotarget
Oncology
2017English

Targeting HSF1 Sensitizes Cancer Cells to HSP90 Inhibition

Oncotarget
Oncology
2013English

Simultaneous Activation and Inhibition of Autophagy Sensitizes Cancer Cells to Chemotherapy

Oncotarget
Oncology
2016English

Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy

Clinical Cancer Research
Cancer ResearchOncology
2013English

Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin

2016English

Momelotinib Sensitizes Glioblastoma Cells to Temozolomide by Enhancement of Autophagy via JAK2/STAT3 Inhibition

Oncology Reports
MedicineCancer ResearchOncology
2019English

Base Excision Repair Inhibition by Methoxyamine Impairs Growth and Sensitizes Osteosarcoma Cells to Conventional Treatments

Journal of Cancer Therapy
2014English

Chloroquine Sensitizes MDA-MB-231 Cells to Osimertinib Through Autophagy–apoptosis Crosstalk Pathway

Breast Cancer: Targets and Therapy
Oncology
2019English

Brca2Deficiency Sensitizes Cells to PARP Inhibition

Cancer Research
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy